Lublin

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma2 trials
• Asthma1 trial
• Lung cancer1 trial

Phase

• Phase 1/22 trials
• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• GlaxoSmithKline3 trials
• Tesaro, Inc.1 trial

Running trials

• Active, not recruiting

  Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM

  NCT07150104· Phase 1/2· GlaxoSmithKline· Source

• Active, not recruiting

  Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM

  NCT07084896· Phase 1/2· GlaxoSmithKline· Source

• Active, not recruiting

  Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

  NCT02715284· Phase 1· Tesaro, Inc.· Source

Closed trials

• Completed

  Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

  NCT04719832· Phase 3· GlaxoSmithKline· Source